Wide distribution of Escherichia coli carrying IncF plasmids containing blaNDM-5and rmtB resistance genes from hospitalized patients in England

Jane F. Turton*, Rachel Pike, Claire Perry, Claire Jenkins, Jack A. Turton, Daniele Meunier, Katie L. Hopkins

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Introduction. The New Delhi metallo-β-lactamase (NDM) variant NDM-5 was first described in 2011 in an isolate of Escherichia coli. We noted that a high proportion of isolates of E. coli positive for blaNDM carbapenemase genes submitted to the UK Health Security Agency (formerly Public Health England) between 2019 and mid-2021 carried the blaNDM-5 allele, with many co-harbouring rmtB, rendering them highly resistant to aminoglycosides as well as to most β-lactams. Hypothesis/Gap Statement. This observation suggested that a common plasmid may be circulating. Aim. To compare these isolates and describe the plasmids carrying these resistance elements. Methodology. All isolates were sequenced on an Illumina platform, with five also subjected to long-read nanopore sequencing to provide complete assemblies. The locations of blaNDM-5, rmtB and other associated genetic elements were identified. Susceptibility testing to a wide range of antibiotics was carried out on representative isolates. Results. The 34 isolates co-harbouring blaNDM-5 and rmtB were from 14 hospital groups and six different regions across England and consisted of 11 distinct sequence types. All carried IncF plasmids. Assembly of the NDM plasmids in five isolates revealed that they carried rmtB and blaNDM-5 in an IncF conjugative plasmid ranging in size from 85.5 to 161 kb. All carried a highly conserved region, previously described in E. coli plasmid pHC105-NDM, that included blaTEM-1B and rmtB followed by sequence bounded by two IS26 elements containing ΔISAba125, blaNDM-5' ble, trpF and tat followed by ISCR1 and an integron with sul1, aadA2 and dfrA12 cassettes. This arrangement has been described in isolates from other countries and continents, suggesting that such plasmids are widely distributed, at least in E. coli, with similar plasmids also found in Klebsiella pneumoniae. Tested isolates were resistant to most antibiotics except colistin, fosfomycin and tigecycline. Conclusion. These observations suggest that conjugative plasmids carrying a highly conserved resistance gene segment have become widespread in England and elsewhere. This study highlights the value of routine whole-genome sequencing in identifying genetic elements responsible for resistance dissemination.

Original languageEnglish
Article number001569
JournalJournal of Medical Microbiology
Volume71
Issue number8
DOIs
Publication statusPublished - 2022
Externally publishedYes

Bibliographical note

Funding Information:
We are grateful to the UKHSA Central Sequencing Laboratory for carrying out Illumina sequencing of these isolates, and to Aiysha Chaudhry, Ciara Ryan and Chantal Humphreys for carrying out susceptibility testing. We thank staff from hospital laboratories for referring these isolates to us.

Publisher Copyright:
© 2022 Crown Copyright.

Keywords

  • Escherichia coli
  • IncF plasmids
  • aminoglycoside resistance
  • carbapenem resistance
  • nanopore sequencing
  • rmtB

Fingerprint

Dive into the research topics of 'Wide distribution of Escherichia coli carrying IncF plasmids containing blaNDM-5and rmtB resistance genes from hospitalized patients in England'. Together they form a unique fingerprint.

Cite this